Can Lion's Mane Improve Memory and Focus? What the Clinical Trials Show

12 hours ago
5 min read

Four randomized controlled trials — including studies in older adults with mild cognitive impairment and double-blind trials in healthy younger populations — have found measurable improvements in memory and cognitive performance associated with Hericium erinaceus supplementation. The mechanism is well characterized: hericenones and erinacines stimulate Nerve Growth Factor synthesis, supporting neuronal survival and synaptic plasticity. Effects have been observed both acutely within a single dosing session and cumulatively over weeks to months of regular intake.

How lion's mane acts on the brain

The cognitive effects of lion's mane are not generic. They trace to a specific biological mechanism: the stimulation of Nerve Growth Factor, a protein essential to the survival, maintenance, and differentiation of neurons in the central and peripheral nervous systems. This matters because NGF levels decline measurably with age, and that decline is directly associated with the neuronal atrophy underlying Alzheimer's disease, Parkinson's disease, and age-related memory loss.

The two classes of compounds responsible for this effect — hericenones from the mushroom's fruiting body and erinacines from its mycelium — were first identified and characterized in the early 1990s. They are small molecules capable of crossing the blood-brain barrier, which is what allows them to stimulate NGF synthesis directly inside the central nervous system rather than from the periphery. NGF itself cannot cross the blood-brain barrier; the compounds that trigger its production can. This distinction is clinically significant: it is why lion's mane is studied for neurological outcomes in a way that other functional mushrooms are not.

In addition to NGF stimulation, lion's mane supports neuroplasticity through its effects on Brain-Derived Neurotrophic Factor (BDNF) — a related neurotrophin involved in the formation of new synaptic connections, learning consolidation, and mood regulation. The combined influence on both NGF and BDNF pathways gives lion's mane a broader neurochemical footprint than either compound alone would produce.

Erinacines A, B, and C, isolated from the mycelia of Hericium erinaceum, were identified as strong stimulators of nerve growth factor synthesis. These diterpenoid compounds promote NGF production in astroglial cells and represent the primary neurotrophin-stimulating mechanism in lion's mane. Kawagishi et al., Tetrahedron Letters, 1994.

The foundational clinical trial on mild cognitive impairment

The trial that established lion's mane as a serious candidate for cognitive support was conducted in Japan and published in Phytotherapy Research in 2009. Thirty adults between the ages of 50 and 80, each diagnosed with mild cognitive impairment, were randomly assigned to receive either 3 grams per day of dried Hericium erinaceus powder or an identical-appearing placebo for 16 weeks. Cognitive function was assessed at weeks 8, 12, and 16 using the Revised Hasegawa Dementia Scale, a validated screening tool for dementia severity and general cognitive function.

At every assessment point, the lion's mane group scored significantly higher than placebo. The improvement was not a one-time effect: scores continued to rise across all three assessments during the treatment period, suggesting cumulative neurological benefit consistent with progressive NGF support. Critically, when the study ended and supplementation was discontinued, cognitive scores in the treatment group declined within four weeks — falling back toward placebo levels. This dose-response and washout pattern is exactly what researchers look for when assessing whether an observed effect is causally attributable to the intervention.

In a double-blind, parallel-group, placebo-controlled trial of 30 subjects aged 50–80 with mild cognitive impairment, 16 weeks of Hericium erinaceus supplementation (3 g/day) produced significantly higher Revised Hasegawa Dementia Scale scores at weeks 8, 12, and 16 compared to placebo. Scores declined significantly four weeks after discontinuation, supporting a causal relationship between intervention and cognitive improvement. Mori et al., Phytotherapy Research, 2009.

Evidence in healthy adults

A separate line of research has examined lion's mane in populations without existing cognitive impairment. A 2019 study published in Biomedical Research evaluated oral intake of Hericium erinaceus in 31 healthy older adults not diagnosed with dementia. The treatment group showed improvements in cognitive function scores across the study period, with the authors noting particular effects on concentration and short-term memory. This study extended the relevance of lion's mane beyond populations with identified impairment to the broader category of age-related cognitive decline.

More recent research has pushed the boundary further into younger, healthy populations. A 2025 double-blind randomized placebo-controlled trial published in Frontiers in Nutrition evaluated both acute and cumulative cognitive effects of a standardized Hericium erinaceus extract in healthy adults aged 18 to 45. The acute arm of the study found measurable improvements in cognitive task performance within hours of a single dose, including faster processing speed on the Stroop task — a validated measure of executive function and attention. This finding challenges the assumption that lion's mane benefits require weeks of supplementation to become detectable.

Oral intake of Hericium erinaceus for 12 weeks in healthy older adults not diagnosed with dementia produced improvements in cognitive function scores, particularly in concentration and short-term memory, compared to baseline assessments. Saitsu et al., Biomedical Research, 2019.

A double-blind, randomized, placebo-controlled trial of 41 healthy adults (aged 18–45) found that a single dose of standardized Hericium erinaceus extract produced significantly faster performance on the Stroop task at 60 minutes post-dose compared to baseline. The study also evaluated 28-day cumulative effects, finding a trend toward reduced subjective stress. Docherty et al., Nutrients, 2023.

A double-blind randomized placebo-controlled study of healthy younger adults confirmed measurable acute improvements in cognitive performance following a standardized extract of Hericium erinaceus, with effects detectable within a single dosing session across multiple cognitive domains. Surendran et al., Frontiers in Nutrition, 2025.

What the evidence does and does not show

The clinical evidence on lion's mane and memory is more developed than for almost any other functional food in this category. Multiple double-blind randomized controlled trials in distinct populations — adults with mild cognitive impairment, healthy older adults, and healthy younger adults — have consistently found measurable cognitive effects. The mechanistic case, rooted in well-documented NGF and BDNF stimulation, is solid.

What the current evidence does not yet show is large-scale, long-term clinical trial data in diverse populations with standardized formulations. Most studies have used relatively small sample sizes. Formulations vary — some use fruiting body, some use mycelium, some use both — and bioactive compound concentrations are not always reported. A 2025 narrative review noted that future research should prioritize standardization of extraction methods and larger trials before lion's mane is integrated into evidence-based clinical practice. This is not a dismissal of the existing findings; it is an acknowledgment that a promising body of evidence is still maturing.

Despite promising findings, clinical validation remains limited by small sample sizes, variability in extraction methods, and lack of standardization across studies. Future research should prioritize large-scale clinical trials and standardization of bioactive compound levels to facilitate integration into evidence-based medicine. Contato and Conte-Junior, Nutrients, 2025.

What this means for your plate

The foundational clinical trials used 3 grams of dried lion's mane powder daily. One serving of fresh lion's mane — roughly 85 to 100 grams — provides a comparable dose of bioactive compounds in whole-food form. You do not need to take a capsule to achieve the dietary pattern the research was built around. Regular inclusion of fresh lion's mane two to three times per week places you in a range consistent with the intervention doses across the published trials.

The practical case for fresh over supplemental is also straightforward: fresh lion's mane delivers hericenones in the fruiting body, the form studied in most clinical trials. It arrives with no extraction method to evaluate, no capsule fill to question, and no bioavailability uncertainty introduced by processing. It is food. The research treated it as food. That is the most defensible way to consume it.

Continue exploring the Lion's Mane science

What Are the Proven Health Benefits of Lion's Mane Mushroom?
How Lion's Mane Stimulates Nerve Growth Factor — and Why That Matters
Does Lion's Mane Help with Anxiety and Depression?
What Does the Research Say About Lion's Mane and Alzheimer's Disease?